Weight Loss Aid in an Exposed Population

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 14, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Polybrominated Biphenyl Poisoning
Interventions
DRUG

Orlistat

Participants will be instructed to take one 60mg capsule of orlistat with each meal containing fat, up to three capsules daily, for six months.

DRUG

Placebo capsule

Participants will be instructed to take one placebo capsule to match 60mg of orlistat with each meal containing fat, up to three capsules daily, for six months.

DIETARY_SUPPLEMENT

Multivitamin

A multivitamin will be provided to be taken once daily, at bedtime.

Trial Locations (1)

30322

Michele Marcus, Atlanta

All Listed Sponsors
collaborator

Healthway Compounding Pharmacy

INDUSTRY

collaborator

Michigan Public Health Departments

OTHER_GOV

collaborator

National Institute of Environmental Health Sciences (NIEHS)

NIH

lead

Emory University

OTHER

NCT03582722 - Weight Loss Aid in an Exposed Population | Biotech Hunter | Biotech Hunter